(Q37724345)

22 August 2017

1 reference

title

Pharmacokinetics of newer drugs in patients with renal impairment (Part I). (English)

1 reference

22 August 2017

1 reference

Fillastre JP

1

1 reference

PubMed ID

2036748

22 August 2017

Singlas E

series ordinal

2

1 reference

22 August 2017

1 April 1991

1 reference

Clinical Pharmacokinetics

22 August 2017

1 reference

22 August 2017

20

1 reference

22 August 2017

4

1 reference

22 August 2017

293-310

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199120040-00004

22 August 2017

0 references

cites work

Pharmacokinetic observations on piroxicam in young adult, middle-aged and elderly patients

1 reference

12 December 2020

Disposition of cefmetazole in healthy volunteers and patients with impaired renal function

1 reference

12 December 2020

Pharmacokinetics of roxatidine in healthy volunteers

1 reference

12 December 2020

Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

1 reference

12 December 2020

Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis

1 reference

12 December 2020

Clinical pharmacokinetics of cimetidine

1 reference

12 December 2020

Ganciclovir pharmacokinetics during renal impairment

1 reference

12 December 2020

Effect of chronic renal failure on oxaprozin multiple-dose pharmacokinetics

1 reference

12 December 2020

New directions for macrolide antibiotics: structural modifications and in vitro activity

1 reference

12 December 2020

The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin

1 reference

12 December 2020

Pharmacokinetics of cefepime in subjects with renal insufficiency

1 reference

12 December 2020

Pharmacokinetics of teicoplanin in subjects with varying degrees of renal function

1 reference

12 December 2020

Nizatidine, an H2-blocker. Its metabolism and disposition in man.

1 reference

12 December 2020

Structure-activity relationships of the fluoroquinolones

1 reference

12 December 2020

Pharmacokinetics of tenoxicam in patients with impaired renal function

1 reference

12 December 2020

Pharmacokinetics of enoxacin and its oxometabolite following intravenous administration to patients with different degrees of renal impairment

1 reference

12 December 2020

Clinical pharmacokinetics of zidovudine. An overview of current data

1 reference

12 December 2020

Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases

1 reference

12 December 2020

Itraconazole pharmacokinetics in patients with renal dysfunction

1 reference

12 December 2020

Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function

1 reference

12 December 2020

Clinical pharmacokinetics of terbinafine (Lamisil).

1 reference

12 December 2020

Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review

1 reference

12 December 2020

Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis

1 reference

12 December 2020

Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin

1 reference

12 December 2020

Determination of omeprazole and metabolites in plasma and urine by liquid chromatography

1 reference

12 December 2020

Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis

1 reference

12 December 2020

Rimantadine pharmacokinetics after single and multiple doses

1 reference

12 December 2020

Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function

1 reference

12 December 2020

Rimantadine pharmacokinetics in healthy subjects and patients with end-stage renal failure

1 reference

12 December 2020

Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients

1 reference

12 December 2020

Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function

1 reference

12 December 2020

Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults

1 reference

12 December 2020

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

1 reference

12 December 2020

Zidovudine disposition in patients with severe renal impairment: influence of hemodialysis

1 reference

12 December 2020

Pharmacokinetics of [14C]omeprazole in patients with impaired renal function

1 reference

12 December 2020

The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men.

1 reference

12 December 2020

Disposition of roxithromycin in patients with normal and severely impaired renal function

1 reference

12 December 2020

Nabumetone pharmacokinetics in patients with varying degrees of renal impairment

1 reference

12 December 2020

Comparative pharmacokinetics of tromethamine fosfomycin and calcium fosfomycin in young and elderly adults

1 reference

12 December 2020

Pharmacokinetics of zidovudine in a patient on maintenance hemodialysis

1 reference

12 December 2020

Clinical pharmacokinetics of acyclovir

1 reference

12 December 2020

Pharmacokinetics of amoxycillin and clavulanic acid in haemodialysis patients following intravenous administration of Augmentin

1 reference

12 December 2020

Piroxicam pharmacokinetics: recent clinical results relating kinetics and plasma levels to age, sex, and adverse effects

1 reference

12 December 2020

Pharmacokinetics of aspoxicillin in subjects with normal and impaired renal function.

1 reference

12 December 2020

Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Pharmacokinetics and dynamics of famotidine in patients with renal failure

1 reference

12 December 2020

Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome

1 reference

12 December 2020

Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis

1 reference

12 December 2020

Elimination of oral cimetidine in chronic renal failure and during haemodialysis

1 reference

12 December 2020

Pharmacokinetics of single-dose cefmetazole following intramuscular administration of cefmetazole sodium to healthy male volunteers

1 reference

12 December 2020

Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans

1 reference

12 December 2020

Pharmacokinetics of ranitidine in patients with renal failure

1 reference

12 December 2020

Pharmacokinetics of cefpiramide in volunteers with normal or impaired renal function

1 reference

12 December 2020

The elimination of sulbactam alone and combined with ampicillin in patients with renal dysfunction

1 reference

12 December 2020

Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects

1 reference

12 December 2020

Single-dose and steady-state pharmacokinetics of piroxicam in elderly vs young adults

1 reference

12 December 2020

Clinical Pharmacokinetics of Ranitidine

1 reference

12 December 2020

Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failure

1 reference

12 December 2020

Teicoplanin pharmacokinetics in patients with chronic renal failure.

1 reference

12 December 2020

Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome

1 reference

12 December 2020

The pharmacokinetic and bactericidal characteristics of oral cefixime

1 reference

12 December 2020

A pharmacokinetic study of roxatidine acetate in chronic renal failure.

1 reference

12 December 2020

Pharmacokinetics of imipenem and cilastatin in volunteers.

1 reference

12 December 2020

Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans

1 reference

12 December 2020

Clinical pharmacokinetics of systemic antifungal drugs

1 reference

12 December 2020

Pharmacokinetics of roxithromycin in renal and hepatic failure and drug interactions

1 reference

12 December 2020

Comparative pharmacokinetics of zidovudine (AZT) and its metabolite (G.AZT) in healthy subjects and HIV seropositive patients

1 reference

12 December 2020

Steady-state intravenous pharmacokinetics of pirenzepine in patients with differing degrees of renal dysfunction

1 reference

12 December 2020

Imipenem/cilastatin: pharmacokinetic profile in renal insufficiency

1 reference

12 December 2020

Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man.

1 reference

12 December 2020

Pharmacokinetics and metabolism of omeprazole in animals and man--an overview

1 reference

12 December 2020

Disposition of famotidine in renal insufficiency

1 reference

12 December 2020

Roxithromycin: a pharmacokinetic review of a macrolide

1 reference

12 December 2020

Fluconazole treatment of Candida glabrata peritonitis

1 reference

12 December 2020

[Pharmacokinetics of trometamol-fosfomycin in patients with renal insufficiency]

1 reference

12 December 2020

Ranitidine disposition in patients with renal impairment

1 reference

12 December 2020

Single-dose pharmacokinetics of recombinant human erythropoietin in patients with various degrees of renal failure

1 reference

12 December 2020

Nizatidine disposition in subjects with normal and impaired renal function

1 reference

12 December 2020

10.2165/00003088-199120040-00004

Identifiers

DOI

1 reference

PubMed ID

2036748

Dimensions Publication ID

22 August 2017

0 references

1 reference

PubMed ID

2036748